Search Results

YC-1 5mg  | ≥99%

CSNpharm

Lificiguat is an acivator of guanylyl cyclase (sGC) and can bind to the heme-containing domain of the β subunit with Kd of 0.6 μM – 1.1 μM.

More Information Supplier Page

YC-1 250mg  | ≥99%

CSNpharm

Lificiguat is an acivator of guanylyl cyclase (sGC) and can bind to the heme-containing domain of the β subunit with Kd of 0.6 μM – 1.1 μM.

More Information Supplier Page

YC-1 10mg  | ≥99%

CSNpharm

Lificiguat is an acivator of guanylyl cyclase (sGC) and can bind to the heme-containing domain of the β subunit with Kd of 0.6 μM – 1.1 μM.

More Information Supplier Page

Voglibose 10mg  | ≥98%

CSNpharm

Voglibose, an N-substituted derivative of valiolamine, can inhibit α-glucosidase and be used to treat hyperglycemia and its concomitant diseases.

More Information Supplier Page

Voglibose 100mg  | ≥98%

CSNpharm

Voglibose, an N-substituted derivative of valiolamine, can inhibit α-glucosidase and be used to treat hyperglycemia and its concomitant diseases.

More Information Supplier Page

Voglibose 50mg  | ≥98%

CSNpharm

Voglibose, an N-substituted derivative of valiolamine, can inhibit α-glucosidase and be used to treat hyperglycemia and its concomitant diseases.

More Information Supplier Page

Vinpocetine 250mg  | ≥99%

CSNpharm

Vinpocetine is a selective inhibitor for PDE1 with IC50 of 21 μM, it also blocks voltage-gated Na+ channels. It’s a natural product isolated and purified from the herbs of Catharanthus roseus (L.) G. Don.

More Information Supplier Page

Vinpocetine 100mg  | ≥99%

CSNpharm

Vinpocetine is a selective inhibitor for PDE1 with IC50 of 21 μM, it also blocks voltage-gated Na+ channels. It’s a natural product isolated and purified from the herbs of Catharanthus roseus (L.) G. Don.

More Information Supplier Page